Published in Am J Transplant on June 09, 2014
Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med (2016) 5.14
Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg (2016) 1.39
Utility of HLA Antibody Testing in Kidney Transplantation. J Am Soc Nephrol (2015) 0.93
Approach to the Highly Sensitized Kidney Transplant Candidate. Clin J Am Soc Nephrol (2016) 0.89
Pregnancy-Induced Sensitization Promotes Sex Disparity in Living Donor Kidney Transplantation. J Am Soc Nephrol (2017) 0.86
Living Donor Kidney Transplantation: Facilitating Education about Live Kidney Donation--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol (2015) 0.84
Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology. Am J Transplant (2016) 0.80
Desensitization outcomes: quantifying and questioning. Am J Transplant (2014) 0.76
Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study. Transplant Direct (2016) 0.76
Transplantation: Survival benefits of incompatible living donor kidney transplants. Nat Rev Nephrol (2016) 0.75
HLA Matching Trumps Donor Age: Donor-Recipient Pairing Characteristics That Impact Long-Term Success in Living Donor Kidney Transplantation in the Era of Paired Kidney Exchange. Transplant Direct (2016) 0.75
Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study. Ann Surg (2016) 0.75
Desensitization: Overcoming the Immunologic Barriers to Transplantation. J Immunol Res (2017) 0.75
Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine. Can J Kidney Health Dis (2017) 0.75
Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study. Am J Transplant (2017) 0.75
Measuring transplant center performance: The goals are not controversial but the methods and consequences can be. Curr Transplant Rep (2017) 0.75
Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report. Medicine (Baltimore) (2017) 0.75
The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide. Transplant Direct (2017) 0.75
Transplantation: IdeS to desensitize organ allograft recipients. Nat Rev Nephrol (2017) 0.75
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial. Transplantation (2017) 0.75
The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 Transplants. Transplant Direct (2017) 0.75
Kidney transplantation under FK 506. JAMA (1990) 7.45
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob Agents Chemother (1995) 5.74
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob Agents Chemother (1998) 4.95
Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings. Proc Natl Acad Sci U S A (1994) 4.48
Nucleic acid reactivity and conformation. II. Reaction of cytosine and uracil with sodium bisulfite. J Biol Chem (1973) 4.44
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother (1995) 4.27
An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res (2001) 4.16
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
Atypical antipsychotics: are some more atypical than others? Psychopharmacology (Berl) (2000) 3.60
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant (2011) 3.42
Genome-wide survey of protein kinases required for cell cycle progression. Nature (2004) 3.40
"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33
Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol (1992) 3.00
Living near a main road and the risk of wheezing illness in children. Am J Respir Crit Care Med (2001) 2.94
Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J Am Chem Soc (1974) 2.92
Disparities in provision of transplant information affect access to kidney transplantation. Am J Transplant (2011) 2.87
Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomography study. J Neurosci (1997) 2.85
C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant (2006) 2.81
Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis (2001) 2.79
The osmotic integrity of the yeast cell requires a functional PKC1 gene product. Mol Cell Biol (1992) 2.78
Early hospital readmission after kidney transplantation: patient and center-level associations. Am J Transplant (2012) 2.78
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
Clozapine for the treatment of adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry (1992) 2.68
Medical education and health for all. Aust J Public Health (1995) 2.65
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Hormone replacement therapy. N Z Med J (1994) 2.57
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol (2013) 2.51
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
MELD Exceptions and Rates of Waiting List Outcomes. Am J Transplant (2011) 2.47
Erythropoietic differentiation in colonies of cells transformed by Friend virus. Proc Natl Acad Sci U S A (1974) 2.47
Addressing geographic disparities in liver transplantation through redistricting. Am J Transplant (2013) 2.46
Nonsimultaneous chains and dominos in kidney- paired donation-revisited. Am J Transplant (2011) 2.43
Expanding kidney paired donation through participation by compatible pairs. Am J Transplant (2007) 2.41
1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest (1984) 2.39
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br J Pharmacol (1995) 2.38
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
De novo initiation of viral RNA-dependent RNA synthesis. Virology (2001) 2.35
Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant (2013) 2.35
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther (1997) 2.33
Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry (1998) 2.33
Organ donation and utilization in the United States, 1999-2008. Am J Transplant (2010) 2.33
Right lobe living donor liver transplantation. Transplantation (1999) 2.31
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Frailty and early hospital readmission after kidney transplantation. Am J Transplant (2013) 2.29
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. Am J Transplant (2011) 2.26
On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. Biochemistry (1969) 2.25
Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
Neuroanatomical correlates of retrieval in episodic memory: auditory sentence recognition. Proc Natl Acad Sci U S A (1994) 2.23
Malarial hepatitis. J Assoc Physicians India (2003) 2.23
Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant (2009) 2.22
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20
Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India. J Perinatol (2006) 2.16
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
Laparoscopic live donor nephrectomy: the recipient. Transplantation (2000) 2.11
Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology (1992) 2.09
Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09
The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion (2002) 2.06
rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1988) 2.06
Characteristic ribonucleolytic activity of human angiogenin. Biochemistry (1986) 2.06
Kidneys for sale: whose attitudes matter? Am J Transplant (2010) 2.03
Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant (2013) 2.02
Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol (1992) 2.01
Atypical antipsychotics. BMJ (2000) 2.01
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00
Prazosin treatment complicated by acute febrile polyarthritis. Br Med J (1976) 1.97
Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl (2000) 1.96
Human allograft acceptance is associated with immune regulation. J Clin Invest (2000) 1.94
Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92
Realizing the potential of clinical judgment: a real-time strategy for predicting outcomes and cost for medical inpatients. Am J Med (2000) 1.91
Reticulum cell neoplasm, type B, or the "Hodgkin's-like lesion" of the mouse. J Natl Cancer Inst (1968) 1.89
The point system for organ distribution. Transplant Proc (1989) 1.88
Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet (2000) 1.85
Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation (2000) 1.85
Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.84
First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther (1996) 1.83
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
Social media and organ donor registration: the Facebook effect. Am J Transplant (2013) 1.83